PL3810587T3 - Podstawione alkoksypirydynyloindolosulfonoamidy - Google Patents

Podstawione alkoksypirydynyloindolosulfonoamidy

Info

Publication number
PL3810587T3
PL3810587T3 PL19731283.8T PL19731283T PL3810587T3 PL 3810587 T3 PL3810587 T3 PL 3810587T3 PL 19731283 T PL19731283 T PL 19731283T PL 3810587 T3 PL3810587 T3 PL 3810587T3
Authority
PL
Poland
Prior art keywords
indolsulfonamides
alkoxypyridinyl
substituted
substituted alkoxypyridinyl
alkoxypyridinyl indolsulfonamides
Prior art date
Application number
PL19731283.8T
Other languages
English (en)
Inventor
Cécile PEGURIER
Laurent Provins
Emre M. ISIN
Marie LEDECQ
Original Assignee
Ucb Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ucb Pharma Gmbh filed Critical Ucb Pharma Gmbh
Publication of PL3810587T3 publication Critical patent/PL3810587T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
PL19731283.8T 2018-06-20 2019-06-19 Podstawione alkoksypirydynyloindolosulfonoamidy PL3810587T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP18178773.0A EP3584244A1 (en) 2018-06-20 2018-06-20 Substituted alkoxypyridinyl indolsulfonamides
PCT/EP2019/066148 WO2019243398A1 (en) 2018-06-20 2019-06-19 Substituted alkoxypyridinyl indolsulfonamides

Publications (1)

Publication Number Publication Date
PL3810587T3 true PL3810587T3 (pl) 2023-02-06

Family

ID=62715911

Family Applications (1)

Application Number Title Priority Date Filing Date
PL19731283.8T PL3810587T3 (pl) 2018-06-20 2019-06-19 Podstawione alkoksypirydynyloindolosulfonoamidy

Country Status (14)

Country Link
US (1) US11976056B2 (pl)
EP (3) EP3584244A1 (pl)
JP (1) JP7371031B2 (pl)
CN (1) CN112292375B (pl)
CA (1) CA3101086A1 (pl)
DK (1) DK3810587T3 (pl)
ES (1) ES2929829T3 (pl)
HR (1) HRP20221289T1 (pl)
HU (1) HUE060181T2 (pl)
LT (1) LT3810587T (pl)
MX (1) MX2020012823A (pl)
PL (1) PL3810587T3 (pl)
PT (1) PT3810587T (pl)
WO (1) WO2019243398A1 (pl)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113993845A (zh) * 2019-06-17 2022-01-28 优时比制药有限公司 作为治疗cns障碍例如多发性硬化的gpr17调节剂的n-(苯基)-吲哚-3-磺酰胺衍生物和相关化合物
JP2023531358A (ja) * 2020-05-01 2023-07-24 ザ チルドレンズ メディカル センター コーポレーション ミエリン形成を促進する組成物および方法
CN112375027B (zh) * 2020-12-07 2023-03-31 中国药科大学 吲哚磺酰胺类衍生物及其医药用途
PL4298092T3 (pl) * 2021-02-26 2026-03-09 F. Hoffmann-La Roche Ag Nowe pochodne pirymidyn‑2‑ylosulfonamidu
WO2023241960A1 (en) * 2022-06-15 2023-12-21 Basf Se A process for the photolytic chlorination of 3-halopyridine with molecular chlorine
EP4311828A1 (en) * 2022-07-26 2024-01-31 Basf Se A process for the photolytic chlorination of 3-halopyridine with molecular chlorine
CN119546572A (zh) * 2022-07-20 2025-02-28 豪夫迈·罗氏有限公司 新颖的萘基和异喹啉磺酰胺衍生物
WO2024017855A1 (en) * 2022-07-20 2024-01-25 F. Hoffmann-La Roche Ag Novel isothiazol-3-yl and isoxazol-3-yl sulfonamide compounds
EP4558496A1 (en) * 2022-07-20 2025-05-28 F. Hoffmann-La Roche AG Novel pyrimidinyl and triazinyl sulfonamide derivatives
EP4558498A1 (en) 2022-07-20 2025-05-28 F. Hoffmann-La Roche AG Novel imidazopyridine and pyrazolopyridine sulfonamide derivatives
CN119546576A (zh) 2022-07-20 2025-02-28 豪夫迈·罗氏有限公司 新颖的异喹啉酮、吡咯并吡啶酮和噻吩并吡啶酮磺酰胺衍生物
AR130023A1 (es) * 2022-07-28 2024-10-23 Hoffmann La Roche Derivados de indol sulfonamida 7 sustituidos
WO2024023129A1 (en) * 2022-07-28 2024-02-01 F. Hoffmann-La Roche Ag Novel 7-substituted indole sulfonamide derivatives
CA3262954A1 (en) * 2022-08-26 2024-02-29 F. Hoffmann-La Roche Ag NEW DEUTERED PYRIMIDINE-2-YL SULFONAMIDE DERIVATIVES
CN120641397A (zh) * 2022-12-02 2025-09-12 瑞文德医疗公众有限公司 稠合吡咯基磺酰胺化合物
WO2024153233A1 (en) * 2023-01-19 2024-07-25 Nanjing Immunophage Biotech Co., Ltd Compounds and their uses as gpr17 antagonists
GB2700773A (en) * 2024-05-23 2026-03-11 Pheno Therapeutics Ltd Compounds
GB2701173A (en) 2024-05-23 2026-04-22 Pheno Therapeutics Ltd Compounds

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19814084B4 (de) 1998-03-30 2005-12-22 Lts Lohmann Therapie-Systeme Ag D2-Agonist enthaltendes transdermales therapeutisches System zur Behandlung des Parkinson-Syndroms und Verfahren zu seiner Herstellung
SE9904750D0 (sv) 1999-12-23 1999-12-23 Pharmacia & Upjohn Ab New formulation, use and method
EP1741792B1 (en) 2004-04-27 2010-11-03 Takeda Pharmaceutical Company Limited Novel ligand of g-protein-conjugated receptor protein and use thereof
ITMI20042007A1 (it) 2004-10-21 2005-01-21 Consiglio Nazionale Ricerche "modulatori del ricettore gpr17 e loro impieghi terapeutici"
EA200801369A1 (ru) 2005-12-20 2009-02-27 ТЕЙКОКУ ФАРМА ЮЭсЭй, ИНК. Способы трансдермального введения агониста рецептора индолсеротонина и трансдермальные лекарственные формы для применения этого способа
WO2009000262A1 (de) 2007-06-25 2008-12-31 Acino Ag Elektrophoretisches transdermales applikationssystem
US20120172375A1 (en) * 2008-11-07 2012-07-05 Bruce Trapp Compounds and methods of promoting oligodendrocyte precursor differentiation
GB2491520A (en) 2010-03-11 2012-12-05 Jerry Swinford Method and apparatus for washing downhole tubulars and equipment
EP2567698B1 (en) * 2011-09-07 2014-02-12 Rheinische Friedrich-Wilhelms-Universität Bonn GPR 17 agonists and screening assay
EP2850068B1 (en) 2012-05-09 2019-05-29 Universita' degli Studi di Milano N-(phenyl)-2-[[3-(phenyl)-1H-1,2,4-triazol-5-yl]thio]-acetamide derivatives and related compounds as G protein coupled receptor 17 (GPCR17) modulators for use in the treatment of neuro-degenerative diseases
WO2018057989A1 (en) 2016-09-24 2018-03-29 Washington University INHIBITORS OF SARM1 NADase ACTIVITY AND USES THEREOF
TWI754702B (zh) 2016-12-28 2022-02-11 德商Ucb製藥有限公司 (氮雜)吲哚-和苯並呋喃-3-磺醯胺類

Also Published As

Publication number Publication date
PT3810587T (pt) 2022-11-14
JP7371031B2 (ja) 2023-10-30
LT3810587T (lt) 2022-11-25
CA3101086A1 (en) 2019-12-26
MX2020012823A (es) 2021-02-15
EP3810587A1 (en) 2021-04-28
WO2019243398A1 (en) 2019-12-26
HUE060181T2 (hu) 2023-02-28
JP2021527696A (ja) 2021-10-14
CN112292375A (zh) 2021-01-29
EP4086248A1 (en) 2022-11-09
HRP20221289T1 (hr) 2022-12-23
EP3584244A1 (en) 2019-12-25
US11976056B2 (en) 2024-05-07
US20210214337A1 (en) 2021-07-15
ES2929829T3 (es) 2022-12-01
EP3810587B1 (en) 2022-08-10
CN112292375B (zh) 2023-12-05
DK3810587T3 (da) 2022-10-31

Similar Documents

Publication Publication Date Title
DK3793565T3 (en) Mcl-1-inhibitorer
DK3467457T3 (en) Vibrationssensor
DK3759096T3 (en) Cd73-inhibitorer
CA185383S (en) Casque
CA185384S (en) Casque
CA185382S (en) Casque
PT3810587T (pt) Alcoxipiridinilindolsulfonamidas substituídas
CA185385S (en) Casque
DK3872428T3 (en) Indvendigt luftstyringssystem
DK3773537T3 (en) Stat3-hæmmere
DK3554057T3 (en) Audioheadsetsystem
DK3768830T3 (en) Cancerterapi
CA184993S (en) Uroflowmeter
DK3613739T3 (en) Integrin-antagonister
DK3753395T3 (en) Indvendigt luftstyringssystem
CA184991S (en) Uroflowmeter
DK3633783T3 (en) Universal-powerbank
EP3841303C0 (de) Mikrogebläse
DK3801538T3 (en) Tlr7-agonister
DK3768906T3 (en) Træmodul
DK3650069T3 (en) Trakeostomiventil
DK3578923T3 (en) Navigationssystem
GB201801914D0 (en) Mouth-guard
DK3674425T3 (en) Stålwire
DK3570498T3 (en) Adaptivt hvac-styresystem